SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Sun Pharma Advanced Research Company turns black in Q3

03 Feb 2014 Evaluate

Sun Pharma Advanced Research Company has reported results for third quarter ended December 31, 2013.

The company has reported net profit of Rs 30.97 crore for the quarter as compared to a net loss of Rs 24.09 crore for the same quarter in the previous year. Total income from operations of the company has increased around 15 fold at Rs 62.95 crore for quarter under review as compared to Rs 4.22 crore for the quarter ended December 31, 2012.

SPARC is an international pharmaceutical company engaged in research and development of drugs and delivery systems.

Sun Pharma Adv. Res Share Price

148.15 2.15 (1.47%)
10-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Syngene Internation. 404.75
Indegene 490.05
CMS Info Systems 298.60
JITF Infralogistics 333.50
Sagility 42.10
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×